U.S. flag

An official website of the United States government

NM_005045.4(RELN):c.5225G>A (p.Arg1742Gln) AND Inborn genetic diseases

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Sep 5, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002526724.2

Allele description [Variation Report for NM_005045.4(RELN):c.5225G>A (p.Arg1742Gln)]

NM_005045.4(RELN):c.5225G>A (p.Arg1742Gln)

Gene:
RELN:reelin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7q22.1
Genomic location:
Preferred name:
NM_005045.4(RELN):c.5225G>A (p.Arg1742Gln)
HGVS:
  • NC_000007.14:g.103561939C>T
  • NG_011877.2:g.432578G>A
  • NM_005045.4:c.5225G>AMANE SELECT
  • NM_173054.3:c.5225G>A
  • NP_005036.2:p.Arg1742Gln
  • NP_774959.1:p.Arg1742Gln
  • NC_000007.13:g.103202386C>T
  • NM_005045.3:c.5225G>A
Protein change:
R1742Q
Links:
dbSNP: rs199553777
NCBI 1000 Genomes Browser:
rs199553777
Molecular consequence:
  • NM_005045.4:c.5225G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_173054.3:c.5225G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Inborn genetic diseases
Identifiers:
MeSH: D030342; MedGen: C0950123

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003559222Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Uncertain significance
(Sep 5, 2021)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Analysis of reelin as a candidate gene for autism.

Bonora E, Beyer KS, Lamb JA, Parr JR, Klauck SM, Benner A, Paolucci M, Abbott A, Ragoussis I, Poustka A, Bailey AJ, Monaco AP; International Molecular Genetic Study of Autism (IMGSAC)..

Mol Psychiatry. 2003 Oct;8(10):885-92.

PubMed [citation]
PMID:
14515139

The de novo autism spectrum disorder RELN R2290C mutation reduces Reelin secretion and increases protein disulfide isomerase expression.

Lammert DB, Middleton FA, Pan J, Olson EC, Howell BW.

J Neurochem. 2017 Jul;142(1):89-102. doi: 10.1111/jnc.14045. Epub 2017 May 18.

PubMed [citation]
PMID:
28419454
PMCID:
PMC6091860

Details of each submission

From Ambry Genetics, SCV003559222.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

Unlikely to be causative of RELN-related lateral temporal epilepsy (AD) based on population frequency in gnomAD. However, the clinical significance for RELN-related lissencephaly (AR) remains unclear (Bonora, 2003; Lammert, 2017). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024